It is a link for moving within the page.

  1. HOME
  2. About Otsuka
  3. Corporate Profile

About OtsukaCorporate Profile

Our board members and statutory auditors

Tatsuo Higuchi President and Representative Director
Nobuyuki Morishima Executive Deputy President and Representative Director
Susumu Tamai Executive Deputy President
Makoto Inoue Executive Deputy President
Toshiki Sudo Executive Director
(Research and Intellectual Property)
Taku Seriu Executive Director
(Product Safety & Quality Assurance, Pharmacovigilance, Regulatory Affairs and Medical Affairs)
Kabir Nath Executive Director
(North America Pharmaceutical and Global Marketing)
Junji Tashiro Executive Director
(Global Human Resources, Headquarters and Otsuka America, Inc.)
Shinichi Taira Executive Director
(Production)
Akemi Kaneko Executive Director
(Quality)
Mikio Bando Executive Director
(Emerging Countries and OIAA Division*)
Shuichi Takagi Executive Director
(Finance and Business Portfolio Management)
Ichiro Otsuka Executive Director
Nobuo Kouno Standing Audit & Supervisory Board Member
Hiroshi Inaka Standing Audit & Supervisory Board Member
Toshio Shiba Standing Audit & Supervisory Board Member
Hiroshi Sugawara Audit & Supervisory Board Member

* Otsuka International Asia Arab Division

As of March 7, 2019

Corporate profile

Company name Otsuka Pharmaceutical Co., Ltd.
Head office 2-9, Kanda-Tsukasamachi, Chiyoda-ku, Tokyo 101-8535, Japan
Date established August 10, 1964
President Tatsuo Higuchi
Capital 20 billion yen
Employees 5,689 (as of December 31, 2018)
Business description Manufacturing, distributing, exporting, and importing of pharmaceuticals,
clinical testing equipment, medical device and equipment, food products,
cosmetics, and other related products
Business premises 15 branch offices, 54 district office (in Japan)
Research facilities 14 divisions in 5 locations (in Japan)
Factories 7 production sites (in Japan)